Malaria Drug Resistance: A Japanese Compound That Blocks the Parasite's Escape
Nagasaki University and Shionogi have found FPSA, a compound that targets plasmepsin X, the enzyme malaria parasites use to burst out of red blood cells. As artemisinin resistance spreads across Africa, a fresh mechanism of action matters. A look at Japan's global-health drug discovery and where this actually stands.